Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT07821749
NA

A Prospective Study of Cold Exposure in Patients With MASH

Sponsor: Renmin Hospital of Wuhan University

View on ClinicalTrials.gov

Summary

This prospective, single-center, single-arm exploratory study aims to evaluate the safety, feasibility, and potential metabolic and hepatic effects of repeated cold exposure in patients with metabolic dysfunction-associated steatohepatitis (MASH). A total of 11 participants with MASH will undergo cold exposure using a water-perfused cooling suit once daily for approximately 120 minutes over a 3-month intervention period. Liver fat content, liver function, lipid metabolism, body weight, and body mass index will be assessed before and after the intervention. Liver fat content will be evaluated by magnetic resonance imaging proton density fat fraction (MRI-PDFF), and blood tests will include alanine aminotransferase (ALT), aspartate aminotransferase (AST), triglycerides (TG), and total cholesterol (TC). Liver ultrasound or liver stiffness-related measures and noninvasive fibrosis scores will also be evaluated when available. Safety, tolerability, adherence, and cold-related adverse events will be monitored throughout the study.

Official title: A Prospective Clinical Study of Cold Exposure Intervention in Patients With Metabolic Dysfunction-Associated Steatohepatitis

Key Details

Gender

All

Age Range

18 Years - 70 Years

Study Type

INTERVENTIONAL

Enrollment

11

Start Date

2026-07-08

Completion Date

2026-10-08

Last Updated

2026-09-16

Healthy Volunteers

No

Interventions

DEVICE

Water-Perfused Cooling Suit

Participants will receive repeated cold exposure using a water-perfused cooling suit with a target circulating-water temperature of approximately 22°C. The intervention will be performed once daily for approximately 120 minutes over a 3-month period. Each session will include a 10- to 15-minute adaptation period, during which the circulating-water temperature will be gradually reduced according to individual tolerance. The actual circulating-water temperature, exposure duration, tolerability, and adverse reactions will be recorded. Blood pressure, heart rate, body temperature, shivering, and subjective discomfort will be monitored during each session.

Locations (1)

Zhongnan Hospital of Wuhan University

Wuhan, Hubei, China